Retatrutide ZPHC (AQ pen) — 30 mg Premixed Pen

Retatrutide — dual GLP-1 / GIP receptor agonist
30 mg pre-filled aqueous pen • 60 clicks × 0.5 mg

• No mixing required: sterile water-based solution delivered via precision dial-a-dose pen.
• Powerful weight-loss synergy: GLP-1 & GIP activation boosts satiety, slows gastric emptying and improves insulin sensitivity.
• Suggested research titration: 0.5 mg weekly → increase by 0.5 mg every 4 weeks up to 2.5 mg, as tolerated.
• Each click = 0.5 mg: transparent window shows remaining volume; full pen supplies 60 clicks.
• Storage: ship cold; refrigerate 2 – 8 °C once opened; stable 30 days at 25 °C for travel.
• QC: ≥ 99 % purity, endotoxin < 0.03 EU/mg; pen sterilised & tamper-evident.